MedPath

Assess the efficacy of paracetamol for the closure of patent ductus arteriosus (PDA) in preterm infants.

Not Applicable
Conditions
Patent ductus arteriosus (PDA).
Persistent ductus arteriosus
Q 25.0
Registration Number
IRCT2017012718994N2
Lead Sponsor
Vice-Chancellor of Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Less than 32 week gestational age

Exclusion Criteria

Pulmonary artery atresia; aorta coarctation; major maternal anomalies; Hydrops fetalis; pulmonary hypertension; mortality of infants during prophylactic therapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ventilator usage time. Timepoint: Three days after Intervention. Method of measurement: according NICU report.;Hospitalization time. Timepoint: Three days after Intervention. Method of measurement: according NICU report.;Mortality rate of infants. Timepoint: Three days after Intervention. Method of measurement: according NICU report.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath